Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (Nasdaq: FRBN) is a blank-check company sponsored by Forbion, a Netherlands-based venture capital firm with a long track record in European life sciences investing. The SPAC completed its initial public offering in 2021 and is focused on identifying a business combination target within the healthcare and life sciences sector, with a particular emphasis on European opportunities. In March 2023, the company filed an amended quarterly report on Form 10-Q/A with the SEC, reflecting ongoing reporting obligations as the vehicle remained in search of a target. For complete filing history, sponsor details, and deal-status tracking on FRBN, sign up for full data access at SpacDesk.